Glenmark Pharmaceuticals Launches Pump Packs

Glenmark Pharmaceuticals Ltd's Glenmark Therapeutics Inc., USA is pleased to announce the launch1 of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin 2 Gel, 0.1% Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, “The introduction of Adapalene Gel USP, 0.1% (OTC) in a new pump pack enhances consumer experience by offering a convenient and easy to use dispensing option while further strengthening our growing U.S. dermatology portfolio. This launch reflects our commitment to delivering highquality and affordable healthcare solutions that meet evolving consumer needs.” Opinion : This news will have postive impact on the stock price of the company Disclaimer : I do not hold this stock. This is not a buy,sell or hold recommendation